Leading the Way in Life Science Technologies

GEN Exclusives

More »

New Products

More »
June 15, 2012 (Vol. 32 , No. 12)

Cardiomyocyte-Beat Monitor

Click Image To Enlarge +

Roche

The xCELLigence RTCA Cardio Instrument provides predictive information about cardiac safety during drug development by measuring cardiomyocyte beating under physiological conditions in cell culture. Through noninvasive, real-time monitoring in 96-well plates, the system detects drug-induced changes and simultaneously assesses cardiotoxicity and cell contractility. The system can additionally analyze both acute and long-term effects on a cell population.

  • Roche
  • 9115 Hague Rd
  • Indianapolis IN, 46250
  • UNITED STATES

Related To This Company

Related content